195 The Impact of Administration of Leukotriene Receptor Antagonists, Pranlukast-EK to Infants with Bronchial Asthma

BACKGROUND: Bronchial asthma develops by the age of 3 years frequently in childhood in industrialized countries. Pranlukast hydrate, leukotriene receptor antagonists, has been shown to be clinically effective for the treatment of hypersensitivity and childhood asthma. The generic drugs for PLK were...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Ogawa, Norifumi, Mikami, Kentaro, Sato, Masahiko, Mezawa, Kenniti, Iwata, Satoshi, Takazawa, Reiko, Oshiba, Akihiro, Hoshioka, Akira, Noma, Takeshi
Format: Artigo
Jezik:Inglês
Izdano: World Allergy Organization Journal 2012
Teme:
Abstracts of the XXII World Allergy Congress
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3512954/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/01.WOX.0000411952.04837.57
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items